Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1599.52 (Glytoucan)

Id:445ae986-eae2-5e9a-b5e7-d16582cfc583

Glytoucan:G95352VM

Results found

Linked to

	Label	Description
	1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G42841BX-GLYCOSEQ00031839 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G88471OO-GLYCOSEQ00053083 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 has motif 4'-sulfated LDN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G63273GB-GLYCOSEQ00121232 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000084 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G39437XQ-GLYCOSEQ00097040 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000086 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G95352VM-GLYCOSEQ00201206 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G42841BX-GLYCOSEQ00031839 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G88471OO-GLYCOSEQ00053083 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has motif 4'-sulfated LDN

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G63273GB-GLYCOSEQ00121232 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000025 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000084 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G39437XQ-GLYCOSEQ00097040 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000086 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1599.52 has glycosequence GLYGEN.GLYCOSEQUENCE:G95352VM-GLYCOSEQ00201206 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.